Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lineage Cell Therapeutics (LCTX) Goodwill (2019 - 2025)

Historic Goodwill for Lineage Cell Therapeutics (LCTX) over the last 7 years, with Q3 2025 value amounting to $10.7 million.

  • Lineage Cell Therapeutics' Goodwill changed 0.0% to $10.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $10.7 million, marking a year-over-year change of 0.0%. This contributed to the annual value of $10.7 million for FY2024, which is 0.0% changed from last year.
  • Latest data reveals that Lineage Cell Therapeutics reported Goodwill of $10.7 million as of Q3 2025, which was down 0.0% from $10.7 million recorded in Q2 2025.
  • Over the past 5 years, Lineage Cell Therapeutics' Goodwill peaked at $10.7 million during Q1 2021, and registered a low of $10.7 million during Q1 2021.
  • Moreover, its 5-year median value for Goodwill was $10.7 million (2021), whereas its average is $10.7 million.
  • Data for Lineage Cell Therapeutics' Goodwill shows a peak YoY increase of 0.0% (in 2021) and a maximum YoY decrease of 0.0% (in 2021) over the last 5 years.
  • Lineage Cell Therapeutics' Goodwill (Quarter) stood at $10.7 million in 2021, then changed by 0.0% to $10.7 million in 2022, then changed by 0.0% to $10.7 million in 2023, then changed by 0.0% to $10.7 million in 2024, then changed by 0.0% to $10.7 million in 2025.
  • Its last three reported values are $10.7 million in Q3 2025, $10.7 million for Q2 2025, and $10.7 million during Q1 2025.